title: Hyperfibrinolysis during liver transplantation is associated with bleeding.
authors.affiliation: Stéphanie Roullet, MD, Service d'Anesthésie Réanimation 1, Hôpital Pellegrin, CHU de Bordeaux, 33076 Bordeaux cedex, France, Tel.: + 33 5 56 79 56 28, Fax: +33 5 56 79 56 29, E-mail: stephanie.roullet@chu-bordeaux.fr.
authors.forename: Stéphanie
authors.initials: S
authors.lastname: Roullet
authors.forename: Geneviève
authors.initials: G
authors.lastname: Freyburger
authors.forename: Sylvie
authors.initials: S
authors.lastname: Labrouche
authors.forename: Eloïse
authors.initials: E
authors.lastname: Morisse
authors.forename: Laurent
authors.initials: L
authors.lastname: Stecken
authors.forename: Alice
authors.initials: A
authors.lastname: Quinart
authors.forename: Christophe
authors.initials: C
authors.lastname: Laurent
authors.forename: François
authors.initials: F
authors.lastname: Sztark
mesh_terms: D005260:Female; D005342:Fibrinolysis; D006470:Hemorrhage / Q000150:complications*; D006498:Hepatectomy / Q000009:adverse effects; D006801:Humans; D000860:Hypoxia; D017093:Liver Failure / Q000150:complications / Q000601:surgery; D016031:Liver Transplantation / Q000009:adverse effects / Q000379:methods*; D008297:Male; D008875:Middle Aged; D017395:Plasminogen Activator Inhibitor 1 / Q000378:metabolism; D011446:Prospective Studies; D012307:Risk Factors; D010959:Tissue Plasminogen Activator / Q000378:metabolism
chemical_list: D017395:Plasminogen Activator Inhibitor 1; C051321:SERPINE1 protein, human; D010959:Tissue Plasminogen Activator